Skip to main content
FinSpry Logo
FinSpry
SLDB logo
SLDB
(NASDAQ)
Solid Biosciences Inc.
$8.79-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Solid Biosciences Inc. (SLDB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Solid Biosciences Inc. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Buy
Based on 9 unique analysts
(11 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$16.75
↑ 90.56% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SLDB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Yigal Nochomovitz
Citi
BuyReiterates
$14.00
Arthur He CFA
HC Wainwright
BuyReiterates
$20.00 → $25.00
Anupam Rama
JP Morgan
BuyMaintains
$12.00 → $11.00
Laura Chico
Wedbush
BuyMaintains
$16.00
Gil Blum
Needham
BuyReiterates
$19.00
Geulah Livshits
Chardan Capital
BuyReiterates
$15.00
Kristen Kluska
Cantor Fitzgerald
BuyMaintains
$16.00
Sami Corwin
William Blair
BuyMaintains
-
Biren Amin
Piper Sandler
BuyMaintains
$17.00 → $18.00
Gil Blum
Needham
BuyReiterates
$19.00
Kristen Kluska
Cantor Fitzgerald
BuyMaintains
$16.00

Frequently Asked Questions

What is the analyst consensus rating for SLDB?

The analyst consensus rating for SLDB is "Buy" based on 9 analyst recommendations.

What is the average price target for SLDB?

The average 12-month price target for SLDB is $16.75, representing an upside of 90.6% from the current price of $8.79.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.